Skip to main content
logo
INFINITT Healthcare Co., Ltd. (KOSDAQ:071200)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,610.00
-310.00 (-3.13%)
At close: Sep 1, 2026

INFINITT Healthcare Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
64,12926,40537,79816,461131.5722,656
Depreciation & Amortization
2,2432,3352,5942,4982,5612,360
Loss (Gain) From Sale of Assets
2.67-13.93110.675.79-0.461.11
Asset Writedown & Restructuring Costs
--69.14---
Loss (Gain) From Sale of Investments
-48,646-17,981-34,039-15,2118,959-14,071
Loss (Gain) on Equity Investments
-27.47-21.43-41.07-100.77-22.47-65.12
Stock-Based Compensation
--272.16259.91289.45362.53296.16
Provision & Write-off of Bad Debts
318.551,9961,030-162.571,318520.15
Other Operating Activities
4,3641,3204,1913,949-2,9183,300
Change in Accounts Receivable
3,290520.92,25520,33214,4652,921
Change in Inventory
-285.05168.051,022146.13-595.59343.36
Change in Accounts Payable
-3,748-71.69-4,755-19,661-18,878-1,726
Change in Unearned Revenue
-113.2432.7597.38134.0385-5.1
Change in Other Net Operating Assets
-96.16-726.451,2201,5373,285-586.92
Operating Cash Flow
21,43213,69111,81310,2168,75215,944
Operating Cash Flow Growth
188.02%15.90%15.63%16.73%-45.11%-1.31%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-199.52-418.09-329.63-660.08-471.22-520.52
Sale of Property, Plant & Equipment
0.157.221.90.370.4516.56
Sale (Purchase) of Intangibles
-36.11-15.7521.57-57.71-53.8-388.64
Investment in Securities
-17,205-8,400-12,915-26,87611,281-39,471
Other Investing Activities
3,9153,5812,9651,7421,149753.53
Investing Cash Flow
-17,282-4,662-10,225-26,35411,996-39,562

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--1,653-1,958-1,576-1,803-1,487
Net Debt Issued (Repaid)
-1,583-1,653-1,958-1,576-1,803-1,487
Dividends Paid
-4,874-2,437----
Other Financing Activities
-230.07-222.8834.2683.21-45.89-286.83
Financing Cash Flow
-6,688-4,313-1,124-1,492-1,849-1,774

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
758.75196.95598.05-74.84-608.48223.43
Miscellaneous Cash Flow Adjustments
-0-0-00-0-
Net Cash Flow
-1,7794,9131,062-17,70418,291-25,168

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
21,23313,27311,4839,5568,28115,424
Free Cash Flow Growth
203.25%15.59%20.16%15.40%-46.31%3.13%
Free Cash Flow Margin
19.51%12.96%11.99%11.13%9.38%19.73%
Free Cash Flow Per Share
864.09544.50470.89392.03339.72631.52
Levered Free Cash Flow
17,81711,94116,7726,5966,1318,680
Unlevered Free Cash Flow
17,87512,00816,8546,6786,2078,754

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
19.0721.831.6326.7945.89286.83
Cash Income Tax Paid
4,7025,1141,039406.341,717751.71
Change in Working Capital
-951.93-76.45-159.592,488-1,638946.46